Derrick W. S. Chan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Derrick W. S. Chan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Anuradha P. Menon
Department of Paediatrics, Children's Intensive Care, KK Women's and Children's Hospital, Singapore
1 shared publicationJan Hau Lee
Department of Paediatrics, Children's Intensive Care, KK Women's and Children's Hospital, Singapore
1 shared publicationTerrence Thomas
Department of Paediatrics, Pediatric Neurology, KK Women's and Children's Hospital, Singapore
1 shared publicationWei Wei Tan
Department of Pharmacy, KK Women's and Children's Hospital, Singapore, Singapore
1 shared publicationYoke Hwee Chan
Department of Paediatrics, Children's Intensive Care, KK Women's and Children's Hospital, Singapore
1 shared publication
Latest Publications
- Open Access
- 1 March 2015
- Published by SAGE Publications in Child Neurology Open
- Vol. 2 (1)
Use of Magnesium Sulfate Infusion for the Management of Febrile Illness-Related Epilepsy Syndrome
Febrile illness-related epilepsy syndrome is a catastrophic epileptic encephalopathy that is highly refractory to most antiepileptic drugs leading to high morbidity and mortality. The authors report the use of a pediatric infusion protocol of continuous intravenous magnesium sulfate for the control of seizures in 2 children with febrile illness-related epilepsy syndrome refractory to multiple antiepileptic drugs in a pediatric intensive care unit of a tertiary care children’s hospital. Both patients, 2 and 16 years of age, respectively, were treated with continuous magnesium sulfate infusion. Serum magnesium concentrations ranging from 2.1 to 5 mmol/L were achieved. Seizure reduction and cessation were noted in 1 patient with magnesium more than 3.0 mmol/L. No significant adverse effects were observed. Magnesium sulfate infusions can be safely used in pediatric refractory status epilepticus. Magnesium sulfate can be considered in the management of children with febrile illness-related epilepsy syndrome.
- 1 March 2015
- Published by SAGE Publications in Child Neurology Open
- Vol. 2 (1)
Open AccessUse of Magnesium Sulfate Infusion for the Management of Febrile Illness-Related Epilepsy Syndrome
Febrile illness-related epilepsy syndrome is a catastrophic epileptic encephalopathy that is highly refractory to most antiepileptic drugs leading to high morbidity and mortality. The authors report the use of a pediatric infusion protocol of continuous intravenous magnesium sulfate for the control of seizures in 2 children with febrile illness-related epilepsy syndrome refractory to multiple antiepileptic drugs in a pediatric intensive care unit of a tertiary care children’s hospital. Both patients, 2 and 16 years of age, respectively, were treated with continuous magnesium sulfate infusion. Serum magnesium concentrations ranging from 2.1 to 5 mmol/L were achieved. Seizure reduction and cessation were noted in 1 patient with magnesium more than 3.0 mmol/L. No significant adverse effects were observed. Magnesium sulfate infusions can be safely used in pediatric refractory status epilepticus. Magnesium sulfate can be considered in the management of children with febrile illness-related epilepsy syndrome.